CencoraMIL:1COR 55 Net Margin % is 2.09% as of Mar. 2026, which is 254% above its 10-year median of 0.59. GuruFocus rates MIL:1COR with a GF Score™ of 55/100 and a GF Value™ of €233.91 (Fairly Valued). The stock has 1 warning sign investors should review. Among 119 Medical Distribution companies, Cencora ranks worse than 67.23% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Cencora's Net Income for the
three
months ended in Mar. 2026 was €1,420 Mil. Cencora's Revenue for the
three
months ended in Mar. 2026 was €67,778 Mil. Therefore, Cencora's net margin for the quarter that ended in Mar. 2026 was 2.09%.
The historical rank and industry rank for Cencora's Net Margin % or its related term are showing as below:
MIL:1COR'
s Net Margin % Range Over the Past 10 Years
Min: -1.8 Med: 0.59 Max: 0.99
Current: 0.78
MIL:1COR's Net Margin % is ranked worse than 67.23% of 119
companies
in the Medical Distribution industry
Industry Median: 1.53
vs MIL:1COR: 0.78
Cencora (MIL:1COR) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Cencora Net Margin % Related Terms
Cencora Net Margin % Historical Data
* Premium members only.
The historical data trend for Cencora's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1COR vs CAH, MCK, HSIC: Net Margin % Comparison
For the Medical Distribution subindustry, Cencora's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's Net Margin % distribution charts can be found below:
* The bar in red indicates where Cencora's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (MIL:1COR) has a Net Margin % of 2.09% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Cencora and its competitors. This is 254% above median its historical median of 0.59. According to the industry distribution chart, Cencora ranks #80 out of 119 companies in the Medical Distribution industry, placing it in the top 67.2%.
Is Cencora's Net Margin % too high?
Cencora's current Net Margin % of 2.09% is 254% above median its 10-year median of 0.59. The Medical Distribution industry median Net Margin % is 1.53. Cencora's value of 2.09% is 36.6% above this industry median. Based on the distribution chart, Cencora ranks #80 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Cencora has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Net Margin % compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #80 out of 119 companies for Net Margin %. This places Cencora in the lower half of its industry. The industry median Net Margin % is 1.53. Cencora's value of 2.09% is 36.6% above this benchmark. While the company's 10-year median is 0.59 vs. the industry median of 1.53, Cencora has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.53, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cencora's current Net Margin % of 2.09% is 36.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current Net Margin % is 2.09%, which is 254% above median its own 10-year median of 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (MIL:1COR) is currently considered Fairly Valued. The stock's GF Value™ is €233.91, compared to a current price of €229.90 — trading 1.7% below its estimated fair value. The current Net Margin % is 2.09%, which is 254% above median its 10-year median of 0.59 and 36.6% above the Medical Distribution industry median of 1.53. Cencora's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cencora (MIL:1COR), the current Net Margin % is 2.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (MIL:1COR) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be undervalued.
The current stock price of €229.90 is trading 1.7% below its estimated GF Value™ of €233.91.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for MIL:1COR:
Net Margin %: 2.09% (254% above median its 10-year median of 0.59)
GF Value™: €233.91 vs. price of €229.90 (1.7% below fair value)
Industry Position: 36.6% above the Medical Distribution median (#80 of 119)
No single metric tells the full story. See the MIL:1COR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
55GF Score
Get the complete analysis for MIL:1COR
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1COR has been successfully added to your 
